Abbott Laboratories

NYSE:ABT  
118.98
+0.19 (+0.16%)
4:00:00 PM EDT: $118.96 -0.02 (-0.02%)
Products

FDA Approves Labeling Update For Abbott's Heartmate 3 Heart Pump For Use In Pediatric Patients

Published: 12/17/2020 21:56 GMT
Abbott Laboratories (ABT) - FDA Approves Labeling Update for Abbott's Heartmate 3 Heart Pump for Use in Pediatric Patients.
Abbott Laboratories - Abbott's Heartmate 3™ Heart Pump Approved for Use for Pediatric Patients Battling Advanced Heart Failure.